The relationship between exacerbated diabetic peripheral neuropathy and metformin treatment in type 2 diabetes mellitus
Abstract Metformin-treated diabetics (MTD) showed a decrease in cobalamin, a rise in homocysteine, and methylmalonic acid, leading to accentuated diabetic peripheral neuropathy (DPN). This study aimed to determine whether or not metformin is a risk factor for DPN. We compared MTD to non-metformin-tr...
Enregistré dans:
Auteurs principaux: | Manal Mohammed Hashem, Ahmed Esmael, Abdelfattah Kasem Nassar, Mohammed El-Sherif |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/4f2eb751760e4a0dab4c6df1f3f332c1 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Prevalence and Clinical Significance of Subclinical Hypothyroidism in Diabetic Peripheral Neuropathy
par: Allam MA, et autres
Publié: (2021) -
Prevalence of diabetic peripheral neuropathy in patients with type 2 diabetes mellitus at a tertiary referral centre in Singapore
par: Arnold Hu Hanquan, et autres
Publié: (2021) -
The Application of Exercise Training for Diabetic Peripheral Neuropathy
par: Clifton J. Holmes, et autres
Publié: (2021) -
Diabetic Peripheral Neuropathies: A Morphometric Overview
par: Fazan,Valéria Paula Sassoli, et autres
Publié: (2010) -
Electrodiagnostics or Ultrasound for Diagnosing Diabetic Peripheral Neuropathy [Letter]
par: Hernandez Fustes OJ, et autres
Publié: (2021)